Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma

NCT03722355 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

712

Enrollment

NETWORK

Sponsor class

Conditions

Glioma
Glioblastoma Multiforme
Astrocytoma

Interventions

RADIATION: Conventional RT
RADIATION: Hyperfractionated RT
DRUG: Carmustine

Sponsor

Radiation Therapy Oncology Group